REGAIN – an opportunity for people with hearing loss to take part in a clinical trial

REGAIN – an opportunity for people with hearing loss to take part in a clinical trial

A team of researchers and clinicians at UCL’s Ear Institute and the Royal National Throat Nose and Ear Hospital are inviting people with hearing loss to participate in a ground breaking clinical trial to test a new drug treatment for hearing loss.  Currently the only option for people with inner ear hearing loss is to wear a hearing aid, or, for those with severe to profound hearing loss, a cochlear implant. These devices help people to communicate, but do not treat the underlying cause of their hearing loss. With one in six people in the UK having hearing loss, there is an urgent need for new treatments. The researchers of the REGAIN project (REgeneration of inner ear hair cells with GAmma-secretase Inhibitors) have worked for years to develop a new drug that could regenerate inner ear (cochlear) hair cells, and they are now at the stage of testing if the drug is safe to use and if it affects the ability to hear in people.

For more information, please visit the Action on Hearing Loss website, where the REGAIN team have written a guest blog about participating in the trial – just search REGAIn

https://www.actiononhearingloss.org.uk